Zonagen (ZONA) Effects Name Change To Repros Therapeutics Inc. (RPRX)
5/3/2006 2:42:24 PM
More...
|
Zonagen (ZONA) Reports First Quarter 2006 Financial Results
5/1/2006 1:03:23 PM
More...
|
Zonagen (ZONA) Reports Fourth Quarter And Year End 2005 Financial Results
3/13/2006 1:24:26 PM
More...
|
Zonagen (ZONA) Announces 2006 Annual Meeting Of Stockholders
2/8/2006 1:26:27 PM
More...
|
Zonagen (ZONA) Announces Positive Top-Line Results Of Androxal(TM) Study
2/3/2006 11:13:36 AM
More...
|
Zonagen (ZONA) Receives IRB Approval to Commence Phase III Study Of Androxal(TM) For The Treatment Of Testosterone Deficiency
1/9/2006 4:27:19 PM
More...
|
Zonagen (ZONA) Announces U.S. IND For The Study Of Proellex(TM) In The Treatment Of Uterine Fibroids Has Become Effective
12/16/2005 1:12:00 PM
More...
|
Zonagen (ZONA) Reports Third Quarter 2005 Financial Results And Provides Update On Proellex And Androxal Clinical Development Programs
11/11/2005 1:43:51 PM
More...
|
Zonagen (ZONA) Reports Fourth Quarter And Year End 2004 Financial Results And Provides An Update On Company's Core Programs
10/19/2005 5:13:10 PM
More...
|
Zonagen (ZONA) Receives Notification Of Issuance Of U.S. Patent On Progenta
10/19/2005 5:13:03 PM
More...
|
|